Cargando…

Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis

IMPORTANCE: Cardiovascular adverse events (CVAEs) after treatment with BRAF and MEK inhibitors in patients with melanoma remain incompletely characterized. OBJECTIVE: To determine the association of BRAF and MEK inhibitor treatment with CVAEs in patients with melanoma compared with BRAF inhibitor mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mincu, Raluca I., Mahabadi, Amir A., Michel, Lars, Mrotzek, Simone M., Schadendorf, Dirk, Rassaf, Tienush, Totzeck, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692687/ https://www.ncbi.nlm.nih.gov/pubmed/31397860 http://dx.doi.org/10.1001/jamanetworkopen.2019.8890

Ejemplares similares

Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta‐Analysis of More Than 20 000 Patients
por: Totzeck, Matthias, et al.
Publicado: (2017)

Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation – a meta-analysis of more than 17000 patients
por: Mincu, Raluca Ileana, et al.
Publicado: (2019)

Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta‐analysis
por: Michel, Lars, et al.
Publicado: (2020)

Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
por: Hinrichs, Lena, et al.
Publicado: (2020)

ECG Changes in Melanoma Patients Undergoing Cancer Therapy—Data from the ECoR Registry
por: Pohl, Julia, et al.
Publicado: (2020)

Cardiovascular Damage Associated With Chest Irradiation
por: Mrotzek, Simone M., et al.
Publicado: (2020)

Left Ventricular Diastolic Function Following Anthracycline-Based Chemotherapy in Patients with Breast Cancer without Previous Cardiac Disease—A Meta-Analysis
por: Mincu, Raluca I., et al.
Publicado: (2021)

Impact of Cancer in Patients Undergoing Transcatheter Aortic Valve Replacement: A Single-Center Study
por: Lind, Alexander, et al.
Publicado: (2020)

Ticagrelor Leads to Statin-Induced Rhabdomyolysis: A Case Report
por: Mrotzek, Simone M., et al.
Publicado: (2017)

ECG Scoring for the Evaluation of Therapy-Naïve Cancer Patients to Predict Cardiotoxicity
por: Pohl, Julia, et al.
Publicado: (2021)

Frequency and prognosis of CVD and myocardial injury in patients presenting with suspected COVID-19 – The CoV-COR registry
por: Mahabadi, Amir A., et al.
Publicado: (2023)

Heart failure from cancer therapy: can we prevent it?
por: Totzeck, Matthias, et al.
Publicado: (2019)

Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy
por: Pohl, Julia, et al.
Publicado: (2022)

Global longitudinal strain is associated with better outcomes in transcatheter aortic valve replacement
por: Al-Rashid, Fadi, et al.
Publicado: (2020)

Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis
por: Mincu, Raluca-Ileana, et al.
Publicado: (2017)

Assessment of coronary artery disease during hospitalization for cancer treatment
por: Mrotzek, Simone M., et al.
Publicado: (2020)

Cardiotoxicity from immune checkpoint inhibitors
por: Michel, Lars, et al.
Publicado: (2019)

Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity
por: Michel, Lars, et al.
Publicado: (2021)

Epicardial adipose tissue is a robust measure of increased risk of myocardial infarction – a meta-analysis on over 6600 patients and rationale for the EPIC-ACS study
por: Hendricks, Stefanie, et al.
Publicado: (2021)

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis
por: Hendricks, Stefanie, et al.
Publicado: (2022)

Oncocardiology: new challenges, new opportunities
por: Michel, Lars, et al.
Publicado: (2020)

Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management
por: Heinzerling, Lucie, et al.
Publicado: (2019)

Implications of Alterations in Pre-test Probability in the 2019 Update of ESC Guidelines for Chronic Coronary Syndromes on Diagnostic Accuracy of Pharmacological Stress-Echocardiography: A Retrospective Cohort Study
por: Dykun, Iryna, et al.
Publicado: (2021)

Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease()
por: Dykun, Iryna, et al.
Publicado: (2018)

Access site complications following Impella-supported high-risk percutaneous coronary interventions
por: Johannsen, Laura, et al.
Publicado: (2019)

Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies
por: Totzeck, Matthias, et al.
Publicado: (2022)

Safety of BRAF+MEK Inhibitor Combinations: Severe Adverse Event Evaluation
por: Meirson, Tomer, et al.
Publicado: (2020)

Association of echocardiographic measures of left ventricular diastolic dysfunction and hypertrophy with presence of coronary microvascular dysfunction
por: Dykun, Iryna, et al.
Publicado: (2020)

Epicardial adipose tissue differentiates in patients with and without coronary microvascular dysfunction
por: Mahmoud, Ihab, et al.
Publicado: (2021)

Red blood cell transfusion in patients with ST-elevation myocardial infarction—a meta-analysis of more than 21,000 patients
por: Mincu, R. I., et al.
Publicado: (2018)

Pulsed electron avalanche knife (PEAK) PlasmaBlade™ in pacemaker and defibrillator procedures
por: Kaya, Elif, et al.
Publicado: (2017)

Malaise and fatigue following mitral valve repair: case report
por: Hinrichs, Lena, et al.
Publicado: (2018)

Treatment Patterns of Lipid-Lowering Therapy in Patients with Coronary Artery Disease Aged Above and Below 75 Years: A Retrospective Cross-Sectional Study of 1500 Patients in a Tertiary Care Referral Center in Germany
por: Dykun, Iryna, et al.
Publicado: (2020)

Impact of left-ventricular end-diastolic pressure as a predictor of periprocedural hemodynamic deterioration in patients undergoing Impella supported high-risk percutaneous coronary interventions
por: Al-Rashid, Fadi, et al.
Publicado: (2019)

Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross‐sectional and longitudinal analysis using two large national registries
por: Guha, Avirup, et al.
Publicado: (2021)

Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim–Chester disease patients following BRAF inhibitor monotherapy
por: Mazor, Roei D, et al.
Publicado: (2020)

Impact of Diabetes Mellitus on Outcomes after High-Risk Interventional Coronary Procedures
por: Johannsen, Laura, et al.
Publicado: (2020)

PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial Infarction
por: Michel, Lars, et al.
Publicado: (2022)

Epicardial adipose tissue and obstructive coronary artery disease in acute chest pain: the EPIC-ACS study
por: Jehn, Stefanie, et al.
Publicado: (2023)

Utilization of IVUS improves all-cause mortality in patients undergoing invasive coronary angiography
por: Dykun, Iryna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_elt8fubtg8obo9gei6cenkgc5s